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Objective: To evaluate the association between clinical, pulmonary, and cardiovascular ﬁnd-
ings  in patients with sickle cell disease and, secondarily, to compare these ﬁndings between
sickle cell anemia patients and those with other sickle cell diseases.
Methods: Fifty-nine adults were included in this cross-sectional study; 47 had sickle cell
anemia, and 12 had other sickle cell diseases. All patients underwent pulmonary function
tests, chest computed tomography, and echocardiography.
Results: Abnormalities on computed tomography, echocardiography, and pulmonary func-
tion  tests were observed in 93.5%, 75.0%; and 70.2% of patients, respectively. A higher
frequency of restrictive abnormalities was observed in patients with a history of acute
chest syndrome (85% vs. 21.6%; p-value < 0.0001) and among patients with increased left
ventricle size (48.2% vs. 22.2%; p-value = 0.036), and a higher frequency of reduced respi-
ratory muscle strength was observed in patients with a ground-glass pattern (33.3% vs.
4.3%; p-value = 0.016). Moreover, a higher frequency of mosaic attenuation was observed in
patients with elevated tricuspid regurgitation velocity (61.1% vs. 24%; p-value = 0.014). Com-
pared to patients with other sickle cell diseases, sickle cell anemia patients had suffered
increased frequencies of acute pain episodes, and acute chest syndrome, and exhibited
mosaic attenuation on computed tomography, and abnormalities on echocardiography.
Conclusion: A signiﬁcant interrelation between abnormalities of the pulmonary and cardio-
vascular systems was observed in sickle cell disease patients. Furthermore, the severity of
the  cardiopulmonary parameters among patients with sickle cell anemia was greater than
that  of patients with other sickle cell diseases.o Bra© 2015 Associac¸ã∗ Corresponding author at: Rua Araguaia, 1266, bloco 1/405, Freguesia, J
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Introduction
Sickle cell disease (SCD), the most common monogenic hered-
itary condition in Brazil and worldwide, it affects more  than 30
million people.1 It is estimated that 4% of the Brazilian popula-
tion has the sickle cell trait and that between 25,000 and 50,000
individuals have the disease in the homozygous (SS) or com-
pound heterozygous states (SC, SE, SD, and S-thalassemia).2
In Brazil, SCD is unevenly distributed among the population,
as it is more  prevalent in the Brazilian states with the greatest
numbers of individuals who are descendants of slaves.3
SCD is characterized by the presence of phenotypes that
range from almost no symptoms to severe symptoms. Its
onset occurs during the ﬁrst year of life, and the disease
extends throughout life; it is associated with high morbidity
and mortality.4 The symptoms are due to hemolytic anemia
and cause severely painful episodes; life-threatening com-
plications due to bacterial sepsis, and splenic sequestration,
acute chest syndrome (ACS), and chronic organ damage are
also observed. All of these complications are due, at least
in part, to chronic hemolysis and episodes of intermittent
vascular occlusion, which lead to tissue injury and organ dys-
function. Advances in the care of SCD patients have led to
increased survival, which in turn has led to the increased
occurrence of chronic damage.5,6
The lung is one of the organs most involved in SCD.7 It is
estimated that approximately 90% of adults with SCD have
abnormal pulmonary function.8 Chronic lung disease is likely
associated with recurrent episodes of ACS caused by infec-
tions, fat embolism, and pulmonary infarction.1,5,9 Pulmonary
hypertension (PH) is believed to be a major cause of death
in adult patients, although more  recently, its incidence and
pathophysiology have been extensively debated.10,11 Impor-
tantly, only 10% of SCD patients are monitored for early
detection of PH.5 Its pathophysiological mechanism is com-
plex and probably multifactorial.11,12
Cardiovascular complications have been increasingly diag-
nosed due to the increased longevity of SCD patients,13 who
have enlarged heart chambers, an alteration that begins in
adolescence.11 Cardiomegaly, chest hyperactivity, and heart
murmurs are often present, mostly secondary to a state of
chronic anemia, PH, and microcirculatory obstruction related
to hemoglobinopathies.11,14 Cardiac iron overload is a pos-
tulated but unproven mechanism in SCD patients.14 Heart
failure is uncommon, and its presence is associated with
older age, coexistence of systemic hypertension and kidney
failure.14 Little has been reported in the literature about the
impact of the homozygous or heterozygous states on hemo-
dynamic changes.11,15
Due to the increased life expectancy of SCD patients, many
morphological and functional parameters associated with the
respiratory and cardiovascular systems need to be elucidated
to allow these parameters to be incorporated into patient
follow-up. The hypothesis of this research was that there is
a relationship between abnormalities of the respiratory and
cardiovascular systems in adults with SCD. Therefore, the
present study aimed to evaluate the association between clin-
ical, pulmonary, and cardiovascular ﬁndings in SCD patients
and, secondarily, to compare these ﬁndings between patientsr. 2 0 1 6;3 8(1):21–27
with sickle cell anemia (SCA) and patients with other sickle
cell diseases (OSCD).
Methods
This cross-sectional study was conducted between May 2013
and June 2015 and evaluated patients with SCD in regular
follow-ups at the Hospital Universitário Pedro Ernesto (HUPE)
of the Universidade do Estado do Rio de Janeiro (UERJ). Patients
aged ≥18 years with SCA or OSCD were included. Exclusion
criteria were a blood transfusion within the previous three
months, a vaso-occlusive pain episode within the previous
month, reports of heart disease or lung disease unrelated
to SCD, a smoking history of >10 pack-years, and a history
of respiratory infection in the previous three weeks. Pack-
years was calculated by multiplying the number of packs of
cigarettes smoked per day by the number of years the per-
son had smoked.16 Based on these criteria, twelve patients
were excluded for the following reasons: signiﬁcant history
of smoking (n = 5), blood transfusion in the previous three
months (n = 5), and vaso-occlusive pain episodes in the pre-
vious month (n = 2).
Among the 59 study participants, forty-seven had SCA, and
12 had OSCD (10 patients had the Hemoglobin (Hb) SC form,
and two patients had the Hb SD form). No patient had the
heterozygous S form of SCD. The study was approved by the
Research Ethics Committee of HUPE-UERJ (number 231.033),
and all participants signed an informed consent form. The
study was conducted in accordance with the Helsinki Decla-
ration as revised in 2008.
Using a computerized system (Collins Plus Pulmonary
Function Testing Systems, Warren E. Collins, Inc., Brain-
tree, MA, USA), spirometry, whole-body plethysmography, and
respiratory muscle strength (RMS) were evaluated. The pul-
monary function tests (PFTs) followed the standards and
interpretation established by the American Thoracic Soci-
ety (ATS).17 The equations of Pereira (spirometry) and Neder
(whole-body plethysmography and measurement of RMS)
were used to interpret the functional parameters.18–20 Restric-
tive abnormalities were diagnosed when the total lung
capacity (TLC) was below the lower limits of normal (LLN),
and obstructive abnormalities were diagnosed when the
forced expiratory volume in one second/forced vital capacity
(FEV1/FVC) ratio was below the LLN.17
Chest computed tomography (CT) scans (including the
upper abdomen) were performed using a 64-channel mul-
tislice CT scanner (Brilliance 40, Philips Medical Systems,
Cleveland, OH, USA). The images were acquired in the axial
plane, with the patient supine, using the following techni-
cal parameters: 120 kV and 130–190 mA,  section thickness of
2 mm,  and pitch of 1 between the jugular notch and the
xiphoid process, with maximal inspiration and expiration and
without gantry tilt. After image  acquisition, reconstruction
was performed at high resolution with a 512 × 512 matrix
using a high-frequency algorithm, window width of 1200 HU,
and middle center of −800 HU. Intravenous contrast was not
used in any of the tests performed. The CT ﬁndings were inter-
preted independently by two radiologists, and a consensus
was established in cases of disagreement. The following CT
oter. 2 0 1 6;3 8(1):21–27 23
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Table 1 – Clinical data, lung function, computed
tomography abnormalities, and echocardiography
ﬁndings of 59 patients.
Variable Value – n (%)
Clinical data (n = 59)
Male gender 27 (45.8)
Afro-descendant 59 (100)
History of vaso-occlusive pain episode
None 22 (37.3)
1/year 26 (44.1)
≥2/year 11 (18.7)
History of acute chest syndrome 25  (42.4)
History of asthma 9 (15.3)
History of stroke 6 (10.2)
History of seizures 4 (6.78)
History of avascular necrosis 15 (25.4)
History of acute splenic sequestration 8 (13.6)
History of transfusions
None 16 (27.1)
1/year 31 (52.5)
≥2/year 12 (20.3)
History of infections
None 16 (27.1)
1/year 32 (54.2)
≥2/year 11 (18.7)
History of hospitalizations
None 18 (30.5)
1/year 32 (54.2)
≥2/year 9 (15.3)
Hydroxyurea therapy 34 (57.6)
Lung function (n = 57)
No abnormality 17 (29.8)
Restrictive abnormality 20 (35.1)
Obstructive abnormality 7 (12.3)
Reduced respiratory muscle strength 29 (50.9)
Computed tomography (n = 46)
No abnormality 3 (6.50)
Reticular pattern 10 (21.7)
Ground-glass opaciﬁcation 9 (19.6)
Mosaic attenuation 18 (39.1)
Lobar volume loss 20 (43.5)
Traction bronchiectasis 4 (8.70)
Spleen
No abnormality 6 (13)
Atrophic 36 (78.3)
Splenomegaly 4 (8.70)
Echocardiography (n = 56)
No abnormality
Increased right atrium 6 (10.7)
Increased right ventricle 6 (10.7)
Increased left atrium 37 (66.1)
Increased left ventricle 29 (51.8)
Elevated tricuspid regurgitation velocity 25 (44.6)rev bras hematol hem
ndings were evaluated: reticular pattern, ground-glass opaci-
cation (GGO), mosaic attenuation, lobar volume loss, and
raction bronchiectasis.21,22 The spleen size was also evalu-
ted in this study by CT.
Transthoracic Doppler echocardiography was performed by
he same examiner using an iE33 system (Philips Medical Sys-
ems, MA,  USA). The images were stored on digital media and
eviewed by a second examiner; both examiners were blinded
o the patient groups. Tricuspid regurgitation velocity (TRV)
as considered high when the value was ≥2.5 m s−1.23
tatistical  analysis
he Shapiro–Wilk test was used to evaluate sample homo-
eneity. The results are expressed as median values and
nterquartile ranges or numbers (percentages). Inferential
nalysis included the chi-square test or Fisher’s exact test
o compare the ﬁndings with categorical data and the
ann–Whitney test or Kruskal–Wallis ANOVA to compare
ndings with numerical data. Dunn’s multiple comparison
est was applied to identify subpopulations that differed sig-
iﬁcantly. Data were analyzed using SAS software version 6.11
SAS Institute, Inc., Cary, NC, USA). p-Values < 0.05 were con-
idered statistically signiﬁcant.
esults
he study population (n = 59) included 32 women and 27 men,
ith a median age of 27 (range: 22–39) years. The median Hb
evel was 8.32 (range: 7.60–10) g/dL. Abnormalities on CT scans,
chocardiography, and PFTs were observed in 93.5%, 75.0%,
nd 70.2% of the patients, respectively. The clinical features as
ell as the PFT, CT, and echocardiography results are shown
n Table 1.
A comparison of patients with and without abnormalities
n the PFTs found no signiﬁcant differences in clinical, CT,
r echocardiography ﬁndings. However, a higher frequency of
estrictive abnormalities was observed in the PFTs of patients
ith a history of acute chest syndrome (Figure 1). A higher
requency of reduced RMS  was also observed in the PFTs of
atients with a GGO pattern on CT (Figure 2).
A comparison of patients with and without abnormalities
n CT scans found no signiﬁcant differences in the clini-
al, PFT, or echocardiography ﬁndings. However, the Hb levels
ere signiﬁcantly different between patients with a normal
pleen [8.90 (range: 7.40–10) g/dL], splenic atrophy [8.20 (range:
.70–9.70) g/dL], and splenomegaly [10.9 (range: 10–12) g/dL] on
T scans (p-value = 0.025).
A comparison of patients with and without abnormalities
n echocardiography found a signiﬁcant difference between
atients with and without a mosaic attenuation pattern
bserved on CT scans, as well as a higher frequency of mosaic
ttenuation pattern in patients with abnormal echocardiog-
aphy (50% vs. 15.4%; p-value = 0.033) and with elevated TRV
Figure 3). Moreover, lower serum Hb levels were observed
n patients with abnormal echocardiography [(8.13 (range:
.32–8.37) vs. 10.1 (range: 9.40–11.7) g/dL; p-value = 0.0006)]
nd in those with elevated TRV [8.10 (range: 7.25–9.34) vs.
.42 (range: 7.81–10.6) g/dL; p-value = 0.023]. A comparisonDiastolic dysfunction 9  (16.1)of patients with and without increased left ventricle (LV)
size found a higher frequency of restrictive abnormalities
among those with increased LV size (48.2% vs. 22.2%; p-
value = 0.036). A comparison of patients with and without
24  rev bras hematol hemote
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History of acute chest syndrome
Restrictive abnormality
 No history of acute chest syndrome
85.0
15.0
21.6
78.4
P<.0001
 No restrictive abnormality
Figure 1 – Comparison between patients with and without
a history of acute chest syndrome in relation to restrictive
abnormalities as measured by pulmonary function tests
(chi-square test).
which can be explained, at least in part, by chronic hemol-increased right atrium (RA) size and increased right ventricle
(RV) size revealed a higher frequency of parenchymal abnor-
malities on CT scans (40% vs. 2.6%; p-value = 0.028).
A comparison of SCA and OSCD patients revealed no signiﬁ-
cant age difference [27 (range: 22–41) years in the SCA group vs.
26 (range: 23–36) years in the OSCD group; p-value = 0.90]. How-
ever, Hb levels differed signiﬁcantly between these two groups
[8.10 (range: 7.40–8.90) g/dL in the SCA group vs. 11.1 (range:
10.0–12.9) g/dL in the OSCD group; p-value = 0.0001]. A history
of leg ulcers and priapism was reported in seven and six SCA
patients, respectively; however, none of the OSCD patients had
a history of priapism or leg ulcers. Comparisons of clinical,
PFT, CT, and echocardiography data between the two groups
are shown in Table 2.100
90
80
70
60
50
33.3
66.7
4.3
95.7
40
30
20
10
0
%
P<.016
Ground-glass opacification  No ground-glass opacification
Reduced respiratory
muscle strength
Normal respiratory
muscle strength
Figure 2 – Comparison between patients with and without
a pattern of ground-glass opaciﬁcation in relation to
reduced respiratory muscle strength as measured by
pulmonary function tests (Fisher’s exact test).r. 2 0 1 6;3 8(1):21–27
Discussion
The main ﬁndings of this study are that cardiopulmonary
abnormalities, comprising both the structure and function of
the cardiac and pulmonary systems, are frequent in adults
with SCD. The restrictive abnormalities observed on the PFTs
are associated with a much higher frequency of ACS and
increased LV size. In addition, a signiﬁcant association was
found between decreased RMS  and a higher frequency of a
GGO pattern on CT scans. Patients with elevated TRV showed
a higher frequency of mosaic attenuation on CT scans and
lower serum Hb levels. Compared to the OSCD group, SCA
patients were more  likely to have a history of vaso-occlusive
pain episodes, a history of ACS, a mosaic attenuation pattern
on CT scans, and abnormalities on echocardiography; all of
these ﬁndings showed signiﬁcant differences between the two
groups.
The respiratory and cardiovascular systems are the most
important systems involved in SCD and are responsible for
the signiﬁcant morbidity and mortality of the disease. In the
present study, evaluations using PFTs, CT, and echocardiogra-
phy in adult patients showed a high frequency of impairment
of the lungs (93.5%) and heart (75%), with these results being
similar to those found in other studies.8,10,21,22,24 With an
increasing life expectancy of SCD patients, a higher percentage
of this population is expected to develop chronic complica-
tions, including pulmonary ﬁbrosis and PH.25
Previous studies have suggested that the detection of
abnormalities in PFTs is the ﬁrst clear sign of chronic sickle
cell lung disease; therefore, these tests could be valuable for
patient management and follow-up.7,8 Similar to the studies
conducted by Lunt et al.21 and Sylvester et al.,22 restrictive
abnormalities were observed in 35.1% of the patients evalu-
ated in the current study. An association between restrictive
damage and a higher frequency of ACS was also observed,ysis and repeated episodes of intermittent vascular occlusion,
which lead to tissue damage.8,22 In contrast to the study
100
61.1
P=.014
38.9
76.0
24.0
90
80
70
60
50
40
30
20
10
0
Normal TRVElevated TRV
Mosaic attenuation  No mosaic attenuation
%
Figure 3 – Comparison between patients with and without
elevated tricuspid regurgitation velocity in relation to the
mosaic attenuation pattern shown on chest computed
tomography (chi-square test).
TRV: tricuspid regurgitation velocity.
rev bras hematol hemoter. 2 0 1 6;3 8(1):21–27 25
Table 2 – Clinical ﬁndings, lung function, computed tomography abnormalities, and echocardiography.
Variable SCA group OSCD group p-value
Clinical data (n = 59) (n = 47) (n = 12)
Male gender 22 (46.8) 5 (41.7) 0.83a
Afro-descendant 47 (100) 12 (100) 1.00a
History of vaso-occlusive pain episode
None 13 (27.7) 9 (75) 0.009a
1/year 23 (48.9) 3 (25)
≥2/year 11 (23.4) 0 (0)
History of acute chest syndrome 24 (51.1) 1 (8.30) 0.008b
History of asthma 7 (14.9) 2 (16.7) 0.27a
History of stroke 6  (12.8) 0 (0) 0.24a
History of seizures 4 (8.51) 0 (0) 0.19a
History of avascular necrosis 13 (27.7) 2 (16.7) 0.52a
History of acute splenic sequestration 8 (17) 0 (0) 0.14a
History of transfusions
None 6 (12.8) 10 (83.3) <0.0001a
1/year 29  (61.7) 2 (16.7)
≥2/year 12 (25.5) 0 (0)
History of infections
None 8 (17) 8 (66.7) 0.003a
1/year 29 (61.7) 3 (25)
≥2/year 10 (21.3) 1 (8.33)
History of hospitalizations
None 9 (19.2) 9 (75) 0.001a
1/year 29 (61.7) 3 (25)
≥2/year 9 (19.2) 0 (0)
Hydroxyurea therapy 33 (70.2) 1 (8.30) <0.0001b
Lung function (n = 57) (n = 45) (n = 12)
No abnormality 11 (24.4) 6 (50) 0.088a
Restrictive abnormality 18 (40) 2 (16.7) 0.12a
Obstructive abnormality 6 (13.3) 1 (8.33) 0.54a
Reduced respiratory muscle strength 23 (51.1) 6 (50) 0.95b
Computed tomography (n = 46) (n = 37) (n = 9)
No abnormality 2 (5.40) 1 (11.1) 0.49a
Reticular pattern 9 (24.3) 1 (11.1) 0.36a
Ground-glass opaciﬁcation 7 (18.9) 2 (22.2) 0.57a
Mosaic attenuation 17 (46) 1 (11.1) 0.038a
Lobar volume loss 15 (40.5) 5 (55.6) 0.33a
Traction bronchiectasis 4 (10.8) 0 (0) 0.41a
Spleen
No abnormality 4 (10.8) 2 (22.2) 0.0001a
Atrophic 33 (89.2) 3 (33.3)
Splenomegaly 0 (0) 4 (44.4)
Echocardiography (n = 56) (n = 44) (n = 12)
No abnormality 6 (13.6) 8 (66.7) 0.0006a
Increased right atrium 6 (13.6) 0 (0) 0.22a
Increased right ventricle 6 (13.6) 0 (0) 0.22a
Increased left atrium 33 (75) 4 (33.3) 0.010a
Increased left ventricle 27 (61.4) 2 (16.7) 0.006b
Elevated tricuspid regurgitation velocity 24 (54.6) 1 (8.33) 0.004b
Diastolic dysfunction 8 (18.2) 1 (8.33) 0.61a
Results expressed as numbers (percentages). SCA: sickle cell anemia; OSCD: other sickle cell diseases.
a Comparison using the Fisher’s exact test.
b Comparison using the chi-square test.
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by Delclaux et al.,24 which found no association between
echocardiographic ﬁndings and the parameters obtained in
the PFTs, an association between restrictive abnormalities
and increased LV size was observed in this study. This is not
surprising because LV dilation can reduce lung volume via sev-
eral mechanisms, including pulmonary congestion and the
direct effect of compression of the heart on the pulmonary
parenchyma.26 Therefore, a cardiac evaluation should be per-
formed in the absence of an apparent pulmonary cause that
justiﬁes the restrictive abnormality observed in PFTs.
In the present study, the impairment of RMS was observed
in 50% of patients and was the most commonly observed
abnormality in the PFTs. Ohara et al.27 recently reported cases
of weakness of the respiratory muscles in SCD patients. Sev-
eral mechanisms may be involved in decreased RMS in these
patients, including shallow breathing due to chest pain, sub-
acute vaso-occlusion, which affects muscle performance, and
deformities of the thoracic cavity resulting from successive
bone infarctions and osteoporosis.27,28 Interestingly, an asso-
ciation between decreased RMS  and the appearance of a GGO
pattern on CT scans was found in the current study. Previ-
ous research had reported a high frequency of a GGO pattern
in SCD patients but did not evaluate its association with
pulmonary function.8,21,22 The GGO pattern on CT scans is
nonspeciﬁc and may reﬂect the occurrence of different mech-
anisms. The results of this study suggest that the partial
collapse of the airway spaces after inspiration resulting from
respiratory muscle weakness could explain, at least in part,
this association.29
Recent studies have shown that increased cardiac output,
rather than primary changes in pulmonary microvascula-
ture, appears to be responsible for changes in pulmonary
hemodynamics in SCD patients.10,11 Mushemi-Blake et al.10
recently demonstrated, via right heart catheterization (RHC),
that although more  than 35% of patients have elevated TRV,
less than 5% have PH. Therefore, the present study used
the measurement of TRV instead of the estimation of sys-
tolic pulmonary artery pressure. Interestingly, an association
between elevated TRV and the appearance of a mosaic atten-
uation pattern on CT was observed, which is indicative of
both occlusive vascular disease and obstructive disease of
the small airways.30 The elevated TRV and low serum Hb
levels observed in the present study have been reported
previously.10
The present study showed higher frequencies of history of
vaso-occlusive pain episodes, history of ACS, a mosaic atten-
uation pattern on CT scans, and echocardiographic changes
in SCA patients than in those with OSCD. However, no signiﬁ-
cant differences were observed in the parameters found in the
PFTs. Koumbourlis et al.15 observed normal pulmonary func-
tion in children with the Hb SC form of SCD and decreases
in pulmonary function over time in a manner similar to that
observed in SCA children. Because this study evaluated only
adult patients, the absence of signiﬁcant differences between
the two groups in the PFTs seems to be supported, at least in
part, by the progressive decline in lung function that occurs
from childhood to adulthood. Notably, the two groups pre-
sented a high percentage of patients with reduced RMS (51.1%
vs. 50.0%).r. 2 0 1 6;3 8(1):21–27
Some limitations of this study should be mentioned. First,
the small sample size of the study and its cross-sectional
nature limit an analysis of cause and effect. Second, RHC,
which could help assess the impact of cardiopulmonary
hemodynamics on the parameters evaluated, was not per-
formed in the study participants. However, RHC is an invasive
method and has inherent risks, which makes its implemen-
tation impractical in all patients. Despite these limitations,
the results justify further research on certain aspects of SCD,
including the involvement of RMS, as it may elucidate the
pathophysiological mechanisms involved in this disease and
assist in the design of rehabilitation programs.
Conclusion
In SCD patients, a signiﬁcant interrelation between abnor-
malities of the structure and function of pulmonary and
cardiovascular systems was observed. Restrictive abnormal-
ities are associated with increased LV size, whereas a mosaic
attenuation pattern on CT scans is associated with ele-
vated TRV. In these patients, an association was observed
between reduced RMS and the appearance of a GGO pattern
on CT scans. Furthermore, the severity of the cardiopulmonary
parameters among SCA patients was higher than that among
OSCD patients.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
1. Machado RF, Gladwin MT. Pulmonary hypertension in
hemolytic disorders: pulmonary vascular disease: the global
perspective. Chest. 2010;137 6 Suppl.:30S–8S.
2. Canc¸ado R, Jesus JA. A doenc¸a falciforme no Brasil. Rev Bras
Hematol Hemoter. 2007;29(3):204–6.
3. Loggetto SR. Sickle cell anemia: clinical diversity and beta
S-globin haplotypes. Rev Bras Hematol Hemoter.
2013;35(3):153–62.
4. Steinberg MH. Predicting clinical severity in sickle cell
anaemia. Br J Haematol. 2005;129(4):465–81.
5. Castro O, Gladwin MT. Pulmonary hypertension in sickle cell
disease: mechanisms, diagnosis and management. Hematol
Oncol Clin North Am. 2005;19(5):881–96.
6. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new
concepts, and future promise. J Clin Invest. 2007;117(4):850–8.
7. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C.
Sickle cell chronic lung disease: prior morbidity and the risk
of  pulmonary failure. Medicine (Baltimore). 1988;67(1):66–76.
8. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal
pulmonary function in adults with sickle cell anemia. Am J
Respir Crit Care Med. 2006;173(11):1264–9.
9. Miller AC, Gladwin MT. Pulmonary complications of sickle cell
disease. Am J Respir Crit Care Med. 2012;185(11):1154–65.SR,  et al. Pulmonary haemodynamics in sickle cell disease are
driven predominantly by a high-output state rather than
elevated pulmonary vascular resistance: a prospective
oter. 
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
30. Sherrick AD, Swensen SJ, Hartman TE. Mosaic pattern of lungrev bras hematol hem
3-dimensional echocardiography/Doppler study. PLOS ONE.
2015;10(8):e0135472.
1. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, et al. A
hemodynamic study of pulmonary hypertension in sickle cell
disease. N Engl J Med. 2011;365(1):44–53.
2. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF,
Minter K, et al. Pulmonary hypertension as a risk factor for
death in patients with sickle cell disease. N Engl J Med.
2004;350(9):886–95.
3. Vasconcelos MC, Nunes MC, Barbosa MM, Fernandes BM,
Passaglia LG, Silva CM, et al. Left ventricular remodeling in
patients with sickle cell disease: determinants factors and
impact on outcome. Ann Hematol. 2015;94(10):1621–9.
4. Gladwin MT, Sachdev V. Cardiovascular abnormalities in
sickle cell disease. J Am Coll Cardiol. 2012;59(13):1123–33.
5. Koumbourlis AC, Lee DJ, Lee A. Lung function and somatic
growth in patients with hemoglobin SC sickle cell disease.
Pediatr Pulmonol. 2008;43(2):175–8.
6. Murray JF, Nadel JA. Textbook of respiratory medicine. 2nd ed.
Philadelphia: WB  Saunders Company; 1994, 2739 pp.
7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R,
Coates A, et al. Standardization of spirometry. Eur Respir J.
2005;26(2):319–38.
8. Pereira CA, Sato T, Rodrigues SC. New reference values for
forced spirometry in white adults in Brazil. J Bras Pneumol.
2007;33(4):397–406.
9. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference
values for lung function tests. I. Static volumes. Braz J Med
Biol Res. 1999;32(6):703–17.
0. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values
for lung function tests. II. Maximal respiratory pressures and
voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719–27.
1. Lunt A, Desai SR, Wells AU, Hansell DM, Mushemi S, Melikian
N,  et al. Pulmonary function, CT and echocardiographic
abnormalities in sickle cell disease. Thorax. 2014;69(8):746–51.2 0 1 6;3 8(1):21–27 27
2. Sylvester KP, Desai SR, Wells AU, Hansell DM, Awogbade M,
Thein SL, et al. Computed tomography and pulmonary
function abnormalities in sickle cell disease. Eur Respir J.
2006;28(4):832–8.
3. Lang RM, Badano LP, Mor-Avi V, Aﬁlalo J, Armstrong A,
Ernande L, et al. Recommendations for cardiac chamber
quantiﬁcation by echocardiography in adults: an update from
the American Society of Echocardiography and the European
Association of Cardiovascular Imaging. Eur Heart J Cardiovasc
Imaging. 2015;16(3):233–70.
4. Delclaux C, Zerah-Lancner F, Bachir D, Habibi A, Monin JL,
Godeau B, et al. Factors associated with dyspnea in adult
patients with sickle cell disease. Chest. 2005;128(5):
3336–44.
5. Vij R, Machado RF. Pulmonary complications of
hemoglobinopathies. Chest. 2010;138(4):973–83.
6. Mottram CD. Ruppel’s manual of pulmonary function testing.
10th ed. Maryland Heights: Elsevier/Mosby; 2013, 514 pp.
7. Ohara DG, Ruas G, Walsh IA, Castro SS, Jamami M. Lung
function and six-minute walk test performance in individuals
with sickle cell disease. Braz J Phys Ther. 2014;18(1):
79–87.
8. Ong BA, Caboot J, Jawad A, McDonough J, Jackson T, Arens R,
et  al. Respiratory muscle force and lung volume changes in a
population of children with sickle cell disease. Br J Haematol.
2013;163(1):112–7.
9. Silva CI, Marchiori E, Souza Júnior AS, Müller NL, Comissão de
Imagem da Sociedade Brasileira de Pneumologia e Tisiologia.
Illustrated Brazilian consensus of terms and fundamental
patterns in chest CT scans. J Bras Pneumol. 2010;36(1):99–123.attenuation non CT scans: frequency among patients with
pulmonary artery hypertension of different causes. AJR Am J
Roentgenol. 1997;169(1):79–82.
